Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload

American Journal of Pathology

Volumn 173, Issue 1, 2008, Pages 289-299

  Vinchi, Francesca ^a   Gastaldi, Stefania ^a   Silengo, Lorenzo ^a   Altruda, Fiorella ^a   Tolosano, Emanuela ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Molecular Biotechnology Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEME; HEME OXYGENASE 1; HEMOPEXIN; PHENYLHYDRAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ENDOTHELIUM LESION; ENZYME INDUCTION; HYPERBILIRUBINEMIA; INFLAMMATION; INTRAVASCULAR HEMOLYSIS; LIVER CONGESTION; LIVER INJURY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION;

EID: 46749135674     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.071130     Document Type: Article

References (48)

1. Kumar S, Bandyopadhyay U: Free heme toxicity and its detoxification systems in human. Toxicol Lett 2005, 157:175-188
2. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG: Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 2003, 55:551-571
3. Balla J, Balla G, Jeney V, Kakuk G, Jacob HS, Vercellotti GM: Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants. Blood 2000, 95:3442-3450
4. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G: Pro-oxidant and cytotoxic effects of circulating heme. Blood 2002, 100:879-887
5. Belcher JD, Bryant CJ, Nguyen J, Bowlin PR, Kielbik MC, Bischof JC, Hebbel RP, Vercellotti GM: Transgenic sickle mice have vascular inflammation. Blood 2003, 101:3953-3959
6. Belcher JD, Mahaseth H, Welch TE, Vilback AE, Sonbol KM, Kalambur VS, Bowlin PR, Bischof JC, Hebbel RP, Vercellotti GM: Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol 2005, 288:H2715-H2725
7. Ascenzi P, Bocedi A, Visca P, Altruda F, Tolosano E, Beringhelli T, Fasano M: Hemoglobin and heme scavenging. IUBMB Life 2005, 57:749-759
8. Tolosano E, Altruda F: Hemopexin: structure, function, and regulation. DNA Cell Biol 2002, 21:297-306
9. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Jacob HS, Eaton JW, Balla G: Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal 9:2119-2137
10. Farombi EO, Surh YJ: Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol 2006, 39:479-491
11. Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK, Tysoe SA, Wolosker H, Baranano DE, Dore S, Poss KD, Snyder SH: Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1999, 1:152-157
12. Kato H, Amersi F, Buelow R, Melinek J, Coito AJ, Ke B, Busuttil RW, Kupiec-Weglinski JW: Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant 2001, 1:121-128
13. Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A: Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 2004, 165:1045-1053
14. Poss KD, Tonegawa S: Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 1997, 94:10919-10924
15. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999, 103:129-135
16. Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, Vercellotti GM: Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 2006, 116:808-816
17. Lim SK, Kim H, Lim SK, bin Ali A, Lim YK, Wang Y, Chong SM, Costantini F, Baumman H: Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 1998, 92:1870-1877
18. Tolosano E, Fagoonee S, Hirsch E, Berger FG, Baumann H, Silengo L, Altruda F: Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. Blood 2002, 100:4201-4208
19. Tolosano E, Hirsch E, Patrucco E, Camaschella C, Navone R, Silengo L, Altruda F: Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice. Blood 1999, 94:3906-3914
20. Hvidberg V, Maniecki MB, Jacobsen C, Hojrup P, Moller HJ, Moestrup SK: Identification of the receptor scavenging hemopexinheme complexes. Blood 2005, 106:2572-2579
21. Santambrogio P, Cozzi A, Levi S, Rovida E, Magni F, Albertini A, Arosio P: Functional and immunological analysis of recombinant mouse H- and L-ferritins from Escherichia coli. Protein Expr Purif 2000, 19:212-218
22. Berry EA, Trumpower BL: Simultaneous determination of hemes a, b, and c from pyridine hemochrome spectra. Anal Biochem 1987, 161:1-15
23. Torti FM, Torti SV: Regulation of ferritin genes and protein. Blood 2002, 99:3505-3516
24. Mukherjee TK, Mishra AK, Mukhopadhyay S, Hoidal JR: High concentration of antioxidants N-acetylcysteine and mitoquinone-Q induces intercellular adhesion molecule 1 and oxidative stress by increasing intracellular glutathione. J Immunol 2007, 178:1835-1844
25. Rajesh M, Mukhopadhyay P, Batkai S, Hasko G, Liaudet L, Huffman JW, Csiszar A, Ungvari Z, Mackie K, Chatterjee S, Pacher P: CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am J Physiol 2007, 293:H2210-H2218
26. Ting HJ, Stice JP, Schaff UY, Hui DY, Rutledge JC, Knowlton AA, Passerini AG, Simon SI: Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ Res 2007, 100:381-390
27. Zhang WJ, Wei H, Hagen T, Frei B: Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad Sci USA 2007, 104:4077-4082
28. Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, van Kooyk Y, de Witte T, Figdor CG: Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 2001, 98:1802-1811
29. Hu C, Dandapat A, Chen J, Liu Y, Hermonat PL, Carey RM, Mehta JL: Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression. Atherosclerosis (in press)
30. Lee YM, Cheng PY, Hong SF, Chen SY, Lam KK, Sheu JR, Yen MH: Oxidative stress induces vascular heme oxygenase-1 expression in ovariectomized rats. Free Radic Biol Med 2005, 39:108-117
31. Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY: Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 1998, 152:711-720
32. Bayraktar UD, Seren S, Bayraktar Y: Hepatic venous outflow obstruction: three similar syndromes. World J Gastroenterol 2007, 13:1912-1927
33. Senzolo M, Germani G, Cholongitas E, Burra P, Burroughs AK: Veno occlusive disease: update on clinical management. World J Gastroenterol 2007, 13:3918-3924
34. Poonkuzhali B, Srivastava A, Quernin MH, Dennison D, Aigrain EJ, Kanagasabapathy AS, Krishnamoorthy R, Chandy M: Pharmacokinetics of oral busulphan in children with beta thalassaemia major undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1999, 24:5-11
35. Srivastava A, Poonkuzhali B, Shaji RV, George B, Mathews V, Chandy M, Krishnamoorthy R: Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. Blood 2004, 104:1574-1577
36. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV: Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995, 333:1253-1258
37. Aydinli M, Bayraktar Y: Budd-Chiari syndrome: etiology, pathogenesis and diagnosis. World J Gastroenterol 2007, 13:2693-2696
38. Ahn H, Li CS, Wang W: Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients. Pediatr Blood Cancer 2005, 45:184-190
39. Dampier C, Setty BN, Eggleston B, Brodecki D, O'Neal P, Stuart M: Vaso-occlusion in children with sickle cell disease: clinical characteristics and biologic correlates. J Pediatr Hematol Oncol 2004, 26:785-790
40. Stuart MJ, Nagel RL: Sickle-cell disease. Lancet 2004, 364:1343-1360
41. Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM: Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 2000, 96:2451-2459
42. Lillis AP, Mikhailenko I, Strickland DK: Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J Thromb Haemost 2005, 3:1884-1893
43. Hentze MW, Muckenthaler MU, Andrews NC: Balancing acts; molecular control of mammalian iron metabolism. Cell 2004, 117:285-297
44. Gburek J, Verroust PJ, Willnow TE, Fyfe JC, Nowacki W, Jacobsen C, Moestrup SK, Christensen EI: Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J Am Soc Nephrol 2002, 13:423-430
45. Abouhamed M, Gburek J, Liu W, Torchalski B, Wilhelm A, Wolff NA, Christensen EI, Thevenod F, Smith CP: Divalent metal transporter 1 in the kidney proximal tubule is expressed in late endosomes/lysosomal membranes: implications for renal handling of protein-metal complexes. Am J Physiol 2006, 290:F1525-F1533
46. Latunde-Dada GO, Simpson RJ, McKie AT: Recent advances in mammalian haem transport. Trends Biochem Sci 2006, 31:182-188
47. Fagoonee S, Gburek J, Hirsch E, Marro S, Moestrup SK, Laurberg JM, Christensen EI, Silengo L, Altruda F, Tolosano E: Plasma protein haptoglobin modulates renal iron loading. Am J Pathol 2005, 166:973-983
48. Marro S, Barisani D, Chiabrando D, Fagoonee S, Muckenthaler MU, Stolte J, Meneveri R, Haile D, Silengo L, Altruda F, Tolosano E: Lack of haptoglobin affects iron transport across duodenum by modulating ferroportin expression. Gastroenterology 2007, 133:1261-1271